CenterVue EIDON Receives 510(k) FDA Clearance

by Business Wire

FREMONT, Calif. & PADOVA, Italy--()--CenterVue, a world leader in eye disease prevention using innovative imaging technologies, today announced FDA 510(k) clearance for its EIDON true-color confocal scanner. EIDON is the first, fully-automated retinal imaging system available in the global eye care market that combines the advantages of confocal scanning with true-color imaging capabilities.

EIDON's white-light, confocal imaging technology facilitates diagnosis and management of retinal disease. The combination of confocal imaging and white light illumination provides greater contrast and superior image quality over a traditional fundus camera. Furthermore, the retinal appearance with EIDON’s white-light source mirrors that as seen during white-light, direct observational techniques. EIDON’s optics allow imaging of the central retina as well as the periphery, over a viewing angle of up to 110 degrees. EIDON's multiple imaging modalities – true-color, red-free, and infrared - provide information concerning different layers of the retina.

See the full article here.

Go to kBLASTER for FDA 510(k) predicate search with effective result management to build your successful 510(k) clearance strategy.